Literature DB >> 6330013

Treatment of canine blastomycosis with amphotericin B and ketoconazole.

A M Legendre, B A Selcer, D F Edwards, R Stevens.   

Abstract

The treatment of 62 dogs with blastomycosis was reviewed to identify prognostic factors and response to various treatment regimens. Severity of lung involvement, as determined by radiography, and the number of nonsegmented neutrophils were useful prognostic factors. Females survived treatment better than did males, but females were more prone to relapse. Ketoconazole treatment at a dose of 10 mg/kg daily for 60 days was not as effective as amphotericin B. The most notable adverse effect of amphotericin B treatment was nephrotoxicosis . Treatment with amphotericin B followed by ketoconazole was as effective as amphotericin B alone and resulted in less nephrotoxicosis . Most dogs that had relapses were retreated effectively with amphotericin B and/or ketoconazole. Canine blastomycosis was shown to be a treatable disease, with a cure rate of approximately 75%.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6330013

Source DB:  PubMed          Journal:  J Am Vet Med Assoc        ISSN: 0003-1488            Impact factor:   1.936


  4 in total

1.  Disseminated blastomycosis in a German shepherd dog.

Authors:  Beverley S Bateman
Journal:  Can Vet J       Date:  2002-07       Impact factor: 1.008

2.  Nephrotoxicity of amphotericin B in dogs: a comparison of two methods of administration.

Authors:  S I Rubin; D R Krawiec; H Gelberg; R D Shanks
Journal:  Can J Vet Res       Date:  1989-01       Impact factor: 1.310

Review 3.  A review of the pathology and treatment of canine respiratory infections.

Authors:  Miranda D Vieson; Pablo Piñeyro; Tanya LeRoith
Journal:  Vet Med (Auckl)       Date:  2012-06-26

4.  Retrospective analysis of the effects of Blastomyces antigen concentration in urine and radiographic findings on survival in dogs with blastomycosis.

Authors:  Laura O Motschenbacher; Eva Furrow; Aaron K Rendahl; Esther G Nell; Kari L Anderson; Lindsay K Merkel; Edward E Patterson
Journal:  J Vet Intern Med       Date:  2021-02-19       Impact factor: 3.333

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.